BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 2072661)

  • 21. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
    Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam.
    Ruan S; O'Donoghue JA; Larson SM; Finn RD; Jungbluth A; Welt S; Humm JL
    J Nucl Med; 2000 Nov; 41(11):1905-12. PubMed ID: 11079503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.
    Katari RS; Fernsten PD; Schlom J
    Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
    Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD
    Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin system.
    Kobayashi H; Sun BF; Yoo TM; Le N; Kim MK; Paik CH; Pastan I; Waldmann TA; Carrasquillo JA
    J Nucl Med; 1999 Aug; 40(8):1381-91. PubMed ID: 10450692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice.
    Zou P; Xu S; Povoski SP; Wang A; Johnson MA; Martin EW; Subramaniam V; Xu R; Sun D
    Mol Pharm; 2009; 6(2):428-40. PubMed ID: 19718796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.
    Kennel SJ; Falcioni R; Wesley JW
    Cancer Res; 1991 Mar; 51(5):1529-36. PubMed ID: 1997194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
    Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
    Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotargeting of human small cell lung cancer xenografts in athymic mice using a monoclonal antibody (RNL-1) against a neuroendocrine-related antigen.
    Mijnheere EP; Boerman OC; Broers JL; Klein Rot M; Vooijs GP; Ramaekers FC
    Br J Cancer Suppl; 1991 Jun; 14():78-81. PubMed ID: 1645579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
    Rogers BE; Roberson PL; Shen S; Khazaeli MB; Carpenter M; Yokoyama S; Brechbiel MW; LoBuglio AF; Buchsbaum DJ
    Cancer Biother Radiopharm; 2005 Oct; 20(5):502-13. PubMed ID: 16248766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5.
    Lopes AD; Davis WL; Rosenstraus MJ; Uveges AJ; Gilman SC
    Cancer Res; 1990 Oct; 50(19):6423-9. PubMed ID: 1698122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of anti lung adenocarcinoma monoclonal antibody recognizing cytokeratin-like cytoplasmic antigen for tumor diagnosis.
    Shitara K; Fujiwara K; Kusano A; Yamaguchi K; Yoshida H; Sato S; Hanai N
    Anticancer Res; 1992; 12(4):1121-9. PubMed ID: 1503402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiolocalization of 99mTc-labeled fragments in a melanoma xenografted model.
    Paganelli G; Viale G; Rossetti C; Magnani P; Sudati F; Vanoli G; Seccamani E; Palmucci F; Fazio F
    J Nucl Biol Med (1991); 1991; 35(1):41-6. PubMed ID: 1932175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates.
    Schott ME; Schlom J; Siler K; Milenic DE; Eggensperger D; Colcher D; Cheng R; Kruper WJ; Fordyce W; Goeckeler W
    Cancer; 1994 Feb; 73(3 Suppl):993-8. PubMed ID: 8306291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning.
    Nieroda CA; Milenic DE; Carrasquillo JA; Scholm J; Greiner JW
    Cancer Res; 1995 Jul; 55(13):2858-65. PubMed ID: 7796413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier.
    Juweid M; Neumann R; Paik C; Perez-Bacete MJ; Sato J; van Osdol W; Weinstein JN
    Cancer Res; 1992 Oct; 52(19):5144-53. PubMed ID: 1327501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and tumor localization of (111)in-labeled HuCC49DeltaC(H)2 in BALB/c mice and athymic murine colon carcinoma xenograft.
    Chinn PC; Morena RA; Santoro DA; Kazules T; Kashmiri SV; Schlom J; Hanna N; Braslawsky G
    Cancer Biother Radiopharm; 2006 Apr; 21(2):106-16. PubMed ID: 16706631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
    Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF
    Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.
    Kashmiri SV; Shu L; Padlan EA; Milenic DE; Schlom J; Hand PH
    Hybridoma; 1995 Oct; 14(5):461-73. PubMed ID: 8575795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.